Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for opioid-induced constipation in chronic non-cancer pain (12-week RCT)
2009-015652-20Phase 3Terminated
- Sponsor
- Movetis
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid-induced constipation (OIC), constipation and Chronic non-cancer pain (CNCP) comparing Prucalopride arm with Placebo arm (2 arms). Started Feb 2010; status: terminated.
02
Drugs
prucalopride
03
Conditions
opioid-induced constipation (OIC)constipationChronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on 2009-015652-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015652-20.